-
The ASCO Post
In a recent study (Dutch Childhood Oncology Group [DCOG] ALL11) reported in the
Journal of Clinical Oncology, Pieters et al found that modifications in therapy appeared to improve outcomes and reduce...
-
About The ASCO Post - The ASCO Post
About The ASCO Post
Established in 2010,
The ASCO Post, in partnership with the American Society of Clinical Oncology (ASCO), communicates news of evidence-based multidisciplinary cancer care to a br...
-
Newsreels - The ASCO Post
Newsreels
Advertisement
The ASCO Post Newsreels help clinicians stay up to date on news in the world of clinical oncology and hematology.
Newsreels feature leading authorities presenting high-impact ...
-
Videos - The ASCO Post
Videos
Advertisement
The ASCO Post Newsreels help clinicians stay up to date on news in the world of clinical oncology and hematology. Newsreels feature leading authorities presenting high-impact cli...
-
Podcasts - The ASCO Post
Podcasts
In this debut episode of
The ASCO Post Podcast, experts in breast, prostate, and lung cancers and multiple myeloma provide clinical insights about selected studies presented at the recent A...
-
New FDA-Approved Oncology Drugs (2021–2022) - The ASCO Post
New FDA-Approved Oncology Drugs (2021–2022)
Advertisement
Over the past year (May 2021–May 2022), the U.S. Food and Drug Administration (FDA) approved and expanded indications for many drugs related t...